The Lancet: World's First Efficacy Results for Sanofi Pasteur Dengue Vaccine Candidate
On September 11, The Lancet published online detailed results of the first ever efficacy study of a candidate dengue vaccine.
The Lancet article details the results of a clinical efficacy study of the Sanofi Pasteur candidate dengue vaccine carried out in Thailand, involving 4,002 children aged 4 to 11 years. The study was conducted in the Muang district of the Ratchaburi Province, in partnership with the Mahidol University and under the patronage of the Thai Ministry of Public Health.
The clinical study results show the ability of the Sanofi Pasteur vaccine candidate to protect against dengue fever caused by three dengue virus types and also confirm the excellent safety profile of the vaccine candidate.
The Lancet: Scientists make dengue vaccine breakthrough
Visit www.dengue.info for information on the Sanofi Pasteur dengue vaccine
